............................................................................................................................................
4.23.08
Aldagen Secures $18.4 Million in Financing
Download PDF
4.15.08
Aldagen Announces Initiation of ALD-101 Phase III Trial for Improving Cord Blood Transplants in Pediatric Patients with Inherited Metabolic Diseases
Download PDF
3.03.08
Aldagen Announces Appointment of David P. Carberry as Chief Financial Officer
Download PDF
1.23.08
Aldagen to Present at Leerink Swann and Wachovia Investor Conferences
Download PDF
12.18.07
Aldagen Appoints Laurence Keller, MD as Chief Medical Officer
Download PDF
12.11.07
Aldagen’s Adult Stem Cell Populations Shown to Regenerate Vascular Function and Repair Liver Damage
Download PDF
11.19.07
Aldagen to Present at 19th Annual Piper Jaffray Health Care Conference
Download PDF
11.15.07
Aldagen Announces Kimbrough as New Board Member
Download PDF
09.13.07
Aldagen Announces Additional Financing
Download PDF
07.12.07
Aldagen Announces Three New CLI Sites
Download PDF
07.02.07
Aldagen Establishes Manufacturing Facility
Download PDF
05.22.07
Aldagen Announces New Board Member
Download PDF
05.10.07
Aldagen Announces Participation in Rodman & Renshaw 4 Annual Global Healthcare Conference
Download PDF
05.08.07
Aldagen Announces Participation in Breakout Session and Business Forum at 2007 BIO International Convention
Download PDF
03.02.07
Aldagen signs worldwide distribution deal for ALDECOUNT® with StemCell Technologies
Download PDF
12.19.06
Aldagen Secures $17.3 Million in Financing
Download PDF
12.15.06
Aldagen Announces Texas Heart Institute as First Site in its Stem Cell Clinical Trial to Treat Critical Limb Ischemia
Download PDF
12.11.06
Interim Results of Clinical Study using Aldagen's Product to Isolate Stem Cells from Cord Blood Presented at American Society of Hematology
Download PDF
10.11.06
Aldagen and IMT Form Regenerative Medicine Alliance to Develop Revolutionary Stem Cell Purification System.
Download PDF
06.07.06
Aldagen to Present at BioDevice Partnering 2006 .
Download PDF
04.13.06
Aldagen IND for Stem Cell Clinical Trial to Treat Critical Limb Ischemia is cleared by FDA.
Download PDF
03.22.06
Aldagen’s Product Used to Isolate Stem Cells from Cord Blood in Human Clinical Study.
Download PDF
03.12.06
Measuring artery repair cells could become new heart disease test.
Download PDF
02.21.06
Aldagen and Texas Heart Institute to Begin Clinical Study of Stem Cell Therapy for Advanced Heart Failure Patients.
Download PDF
02.08.06
Aldagen Issued Key Stem Cell Patent: Patent covers unique method of isolating adult stem cells.
Download PDF
12.12.05
Aldagen’s Products Isolate Human Adult Stem Cells that Can Regenerate Vascular Function.
Download PDF
11.28.05
StemCo Biomedical changes Name to Aldagen, Inc.
Download PDF
09.06.05
StemCo Biomedical signs worldwide distribution deal for ALDEFLUOR with StemCell Technologies.
Download PDF
Print Page
Back to top
designed by
boyldone.com
